Long-chain carboxychromanols and analogs for use as anti-inflammatory agents
Long-chain carboxychromanol compounds useful for treating conditions associated with the need to inhibit cyclooxygenase-1, cyclooxygenase-2, and/or 5-lipoxygenase, and pharmaceutical formulations containing the compounds are provided herein.
1. A pharmaceutical composition comprising a conjugated 13′-carboxychromanol compound
and
a pharmaceutically acceptable polyphenolic sulfation inhibitor, wherein the polyphenolic sulfation inhibitor is sesamin or curcumin.
2. A method for treating a physiological disorder associated with inflammation in the gut, the method comprising administering a therapeutic amount of a conjugated 13′-carboxychromanol compound:
and
a pharmaceutically acceptable polyphenolic sulfation inhibitor, wherein the polyphenolic sulfation inhibitor is sesamin or curcumin.
3. The method of claim 2 , wherein said physiological disorder is selected from the group consisting of inflammatory bowel disease, gastritis, irritable bowel syndrome, ulcerative colitis, Crohn's disease, and diarrhea.
4. The method of claim 2 , wherein said patient is a human.
5. The method of claim 2 , wherein the sufficient amount is from about 5 uM to about 20 uM.